Evotec (EVTCY) Financials

$3.09 -0.02 (-0.64%)

As of 05/1/2026

Annual Income Statements for Evotec

This table shows Evotec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	54	29	244	-188	-93	-203	-121
Consolidated Net Income / (Loss)	42	7.67	244	-188	-93	-203	-121
Net Income / (Loss) Continuing Operations	54	29	244	-188	-93	-203	-121
Total Pre-Tax Income	75	53	268	-165	-89	-201	-102
Total Operating Income	-2.10	-25	46	22	-53	-91	-65
Total Gross Profit	149	154	172	186	194	119	134
Total Revenue	501	612	699	804	864	825	925
Operating Revenue	501	612	699	804	864	825	925
Total Cost of Revenue	352	458	528	618	671	706	791
Operating Cost of Revenue	352	458	528	618	671	706	791
Total Operating Expenses	151	178	125	164	246	210	199
Selling, General & Admin Expense	75	94	119	167	188	195	207
Research & Development Expense	66	78	82	82	76	53	44
Other Operating Expenses / (Income)	11	6.07	-77	-85	-23	-38	-51
Impairment Charge	-	-	0.77	0.00	5.54	0.00	0.00
Total Other Income / (Expense), net	77	78	222	-187	-37	-110	-37
Other Income / (Expense), net	86	88	0.91	13	-37	-110	-37
Income Tax Expense	22	24	24	23	3.67	2.18	20
Weighted Average Basic Shares Outstanding	149.73M	153.75M	166.41M	176.67M	176.92M	177.30M	177.78M
Diluted Earnings per Share	-	-	$2.94	($2.12)	($1.04)	($2.30)	($1.36)
Weighted Average Diluted Shares Outstanding	149.73M	153.75M	166.41M	176.67M	176.92M	177.30M	177.78M
Weighted Average Basic & Diluted Shares Outstanding	149.73M	153.75M	166.41M	176.67M	176.92M	177.30M	177.58M

No quarterly income statements for Evotec are available.

This table details how cash moves in and out of Evotec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	187	166	313	-284	105	-135	146
Net Cash From Operating Activities	47	175	-27	59	296	-27	-11
Net Cash From Continuing Operating Activities	49	175	-27	59	296	-27	-3.16
Net Income / (Loss) Continuing Operations	42	7.67	244	-188	-93	-203	-121
Consolidated Net Income / (Loss)	42	7.67	244	-188	-93	-203	-121
Depreciation Expense	41	51	80	89	103	105	117
Non-Cash Adjustments To Reconcile Net Income	18	89	-354	22	291	71	36
Changes in Operating Assets and Liabilities, net	-65	9.16	3.15	136	-5.55	-	-34
Net Cash From Investing Activities	-97	-28	-136	-284	-265	24	201
Net Cash From Continuing Investing Activities	-81	-28	-136	-284	-265	24	170
Purchase of Property, Plant & Equipment	-36	-	-135	-194	-239	-15	-97
Acquisitions	-45	-	-0.46	-22	-	-	0.00
Sale of Property, Plant & Equipment	-	-	0.00	0.00	0.59	2.07	0.25
Divestitures	-	-	-	-	-	-	261
Sale and/or Maturity of Investments	-	-	31	0.00	-	37	6.06
Other Investing Activities, net	-	-	-	-	-	-	0.00
Net Cash From Financing Activities	237	18	445	-62	94	-132	-44
Net Cash From Continuing Financing Activities	237	18	474	-56	94	-132	-44
Repayment of Debt	-93	-7.96	-18	-57	-150	-133	-92
Repurchase of Common Equity	-	-	-	-	0.00	-	-1.82
Issuance of Debt	328	26	491	0.38	243	0.93	50
Other Financing Activities, net	2.13	-	-	-	-	-	0.26

No quarterly cash flow statements for Evotec are available.

This table presents Evotec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,786	2,530	2,415	2,492	1,980	2,011
Total Current Assets	805	1,246	1,149	999	706	895
Cash & Equivalents	516	791	444	565	317	491
Short-Term Investments	73	180	325	103	94	68
Accounts Receivable	97	149	184	109	120	160
Inventories, net	17	29	32	34	32	39
Prepaid Expenses	37	45	61	57	47	36
Current Deferred & Refundable Income Taxes	27	27	58	89	43	45
Other Current Assets	-	21	33	28	48	33
Other Current Nonoperating Assets	13	0.30	12	14	4.44	24
Plant, Property, & Equipment, net	412	548	696	892	0.00	0.00
Total Noncurrent Assets	570	735	427	447	379	409
Long-Term Investments	72	319	17	3.40	2.21	5.43
Intangible Assets	120	35	319	322	320	357
Noncurrent Deferred & Refundable Income Taxes	74	83	86	120	54	46
Other Noncurrent Operating Assets	1.12	6.81	4.05	0.93	3.59	0.60
Total Liabilities & Shareholders' Equity	1,786	2,530	2,415	2,492	1,980	2,011
Total Liabilities	896	954	579	547	531	526
Total Current Liabilities	255	367	361	514	357	432
Accounts Payable	52	82	104	149	89	76
Current Deferred & Payable Income Tax Liabilities	4.11	12	9.61	6.16	8.82	12
Other Current Liabilities	175	216	208	183	203	217
Total Noncurrent Liabilities	647	603	783	739	637	625
Noncurrent Deferred Revenue	-	-	-	-	32	9.80
Noncurrent Deferred & Payable Income Tax Liabilities	25	20	20	20	15	17
Other Noncurrent Operating Liabilities	53	59	238	190	184	194
Total Equity & Noncontrolling Interests	885	1,559	1,270	1,239	986	955
Total Preferred & Common Equity	885	1,559	1,270	1,239	986	955
Total Common Equity	885	1,559	1,270	1,239	986	955
Common Stock	1,459	1,819	1,730	1,800	1,690	1,920
Retained Earnings	-529	-245	-420	-527	-696	-911
Treasury Stock	-	-	-	-	0.00	-1.82
Accumulated Other Comprehensive Income / (Loss)	-46	-14	-40	-34	-7.60	-53

No quarterly balance sheets for Evotec are available.

This table displays calculated financial ratios and metrics derived from Evotec's official financial filings.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	177,778,907.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	177,778,907.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-0.68
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	22.14%	14.31%	14.93%	7.53%	-4.57%	12.16%
EBITDA Growth	0.00%	-4.88%	-3.63%	-1.85%	-62.47%	-209.62%	115.60%
EBIT Growth	0.00%	-24.44%	-25.24%	-24.69%	-257.42%	-178.98%	49.29%
NOPAT Growth	0.00%	-813.18%	409.02%	-63.00%	-335.61%	-72.52%	28.05%
Net Income Growth	0.00%	-81.68%	3,080.42%	-177.04%	50.60%	-118.65%	40.14%
EPS Growth	0.00%	0.00%	0.00%	-171.98%	50.91%	-121.00%	40.76%
Operating Cash Flow Growth	0.00%	268.44%	-115.43%	-498.15%	81.68%	-109.17%	59.51%
Free Cash Flow Firm Growth	0.00%	0.00%	98.47%	-147.06%	-713.00%	107.59%	-110.92%
Invested Capital Growth	0.00%	0.00%	6.88%	5.44%	23.64%	-7.45%	38.86%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	29.77%	25.10%	24.52%	23.16%	22.40%	14.41%	14.49%
EBITDA Margin	27.65%	21.53%	18.15%	15.50%	5.41%	-6.22%	1.61%
Operating Margin	-0.42%	-4.07%	6.63%	2.77%	-6.08%	-10.99%	-7.05%
EBIT Margin	16.72%	10.34%	6.76%	4.43%	-6.49%	-18.97%	-11.01%
Profit (Net Income) Margin	8.36%	1.25%	34.87%	-23.38%	-10.74%	-24.60%	-13.13%
Tax Burden Percent	55.55%	14.49%	90.94%	114.09%	104.12%	101.08%	119.31%
Interest Burden Percent	90.01%	83.66%	566.99%	-462.32%	158.97%	128.33%	100.00%
Effective Tax Rate	28.83%	45.14%	9.06%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-3.44%	5.14%	1.79%	-3.68%	-5.97%	-27.96%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-49.80%	-45.05%	39.20%	18.28%	280.65%	-18.57%
Return on Net Nonoperating Assets (RNNOA)	0.00%	5.18%	14.81%	-15.08%	-3.72%	-12.28%	15.44%
Return on Equity (ROE)	0.00%	1.73%	19.96%	-13.28%	-7.40%	-18.25%	-12.52%
Cash Return on Invested Capital (CROIC)	0.00%	-203.44%	-1.51%	-3.50%	-24.82%	1.77%	-60.50%
Operating Return on Assets (OROA)	0.00%	3.54%	2.19%	1.44%	-2.29%	-7.00%	-5.10%
Return on Assets (ROA)	0.00%	0.43%	11.30%	-7.60%	-3.78%	-9.08%	-6.09%
Return on Common Equity (ROCE)	0.00%	1.73%	19.96%	-13.28%	-7.40%	-18.25%	-12.52%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.87%	15.64%	-14.80%	-7.49%	-20.59%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.50	-14	42	16	-37	-63	-46
NOPAT Margin	-0.30%	-2.23%	6.03%	1.94%	-4.26%	-7.69%	-4.94%
Net Nonoperating Expense Percent (NNEP)	0.00%	46.36%	50.20%	-37.41%	-21.96%	-286.61%	-9.39%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-6.44%	-4.78%
Cost of Revenue to Revenue	70.23%	74.90%	75.48%	76.84%	77.60%	85.59%	85.51%
SG&A Expenses to Revenue	14.88%	15.41%	17.06%	20.79%	21.71%	23.61%	22.32%
R&D to Revenue	13.09%	12.77%	11.68%	10.20%	8.77%	6.38%	4.76%
Operating Expenses to Revenue	30.19%	29.17%	17.89%	20.39%	28.48%	25.41%	21.54%
Earnings before Interest and Taxes (EBIT)	84	63	47	36	-56	-156	-102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	139	132	127	125	47	-51	15
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.02	0.30	0.56	0.84	0.37	0.29
Price to Tangible Book Value (P/TBV)	0.00	1.95	0.39	0.75	1.13	0.55	0.46
Price to Revenue (P/Rev)	2.05	1.48	0.68	0.89	1.20	0.45	0.30
Price to Earnings (P/E)	19.16	31.16	1.95	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.22%	3.21%	51.35%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.04	0.00	0.00	0.33	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	1.35	0.00	0.00	0.42	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	6.28	0.00	0.00	7.83	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	13.07	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	4.74	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.66	0.36	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.64	0.34	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.10	-0.33	-0.38	-0.20	-0.04	-0.83
Leverage Ratio	0.00	2.02	1.77	1.75	1.96	2.01	2.06
Compound Leverage Factor	0.00	1.69	10.01	-8.08	3.11	2.58	2.06
Debt to Total Capital	0.00%	39.72%	26.57%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	1.28%	1.93%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	38.44%	24.64%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	60.28%	73.43%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	4.43	4.44	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	-0.59	-5.72	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	4.28	4.12	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	-42.71	13.37	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	5.69	-17.21	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	-41.33	12.40	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	1.02	0.92	1.27	1.35	0.32	0.25
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	3.16	3.39	3.18	1.94	1.98	2.07
Quick Ratio	0.00	2.75	3.05	2.64	1.51	1.49	1.66
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-807	-12	-31	-248	19	-99
Operating Cash Flow to CapEx	132.32%	0.00%	-20.00%	-83.02%	-1,242.06%	-201.29%	-11.14%
Free Cash Flow to Firm to Interest Expense	0.00	-78.01	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	5.66	16.88	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.38	16.88	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	0.34	0.32	0.33	0.35	0.37	0.46
Accounts Receivable Turnover	0.00	6.34	5.69	4.82	5.91	7.20	6.61
Inventory Turnover	0.00	27.62	23.06	20.22	20.30	21.27	22.25
Fixed Asset Turnover	0.00	1.49	1.46	1.29	1.09	0.95	0.00
Accounts Payable Turnover	0.00	8.82	7.87	6.63	5.31	5.95	9.60
Days Sales Outstanding (DSO)	0.00	57.57	64.18	75.66	61.78	50.72	55.22
Days Inventory Outstanding (DIO)	0.00	13.22	15.83	18.05	17.98	17.16	16.40
Days Payable Outstanding (DPO)	0.00	41.39	46.37	55.02	68.74	61.36	38.02
Cash Conversion Cycle (CCC)	0.00	29.39	33.64	38.69	11.02	6.51	33.61
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	793	848	894	1,105	1,023	190
Invested Capital Turnover	0.00	1.54	0.85	0.92	0.87	0.78	5.67
Increase / (Decrease) in Invested Capital	0.00	793	55	46	211	-82	53
Enterprise Value (EV)	0.00	827	-251	-71	366	-44	-291
Market Capitalization	1,028	905	475	714	1,038	369	273
Book Value per Share	$0.00	$5.76	$9.37	$7.19	$7.00	$5.56	$5.38
Tangible Book Value per Share	$0.00	$3.01	$7.41	$5.38	$5.18	$3.76	$3.37
Total Capital	0.00	1,468	2,123	1,270	1,239	986	955
Total Debt	0.00	583	564	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	564	523	0.00	0.00	0.00	0.00
Net Debt	0.00	-78	-726	-786	-672	-413	-565
Capital Expenditures (CapEx)	36	0.00	135	194	2.38	13	97
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-20	-52	19	-183	-62	-96
Debt-free Net Working Capital (DFNWC)	0.00	569	920	787	485	349	463
Net Working Capital (NWC)	0.00	550	879	787	485	349	463
Net Nonoperating Expense (NNE)	-43	-21	-202	204	56	139	76
Net Nonoperating Obligations (NNO)	0.00	-92	-712	-376	-134	37	-765
Total Depreciation and Amortization (D&A)	55	68	80	89	103	105	117
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-3.22%	-7.39%	2.33%	-21.18%	-7.46%	-10.34%
Debt-free Net Working Capital to Revenue	0.00%	92.98%	131.48%	97.94%	56.13%	42.33%	50.09%
Net Working Capital to Revenue	0.00%	89.91%	125.63%	97.94%	56.13%	42.33%	50.09%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	176.61M	176.95M	177.19M	177.55M	177.78M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.04)	($2.30)	($1.36)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	176.61M	176.95M	177.19M	177.55M	177.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	166.41M	176.95M	176.92M	177.30M	177.58M
Normalized Net Operating Profit after Tax (NOPAT)	-1.50	-14	43	16	-33	-63	-46
Normalized NOPAT Margin	-0.30%	-2.23%	6.13%	1.94%	-3.81%	-7.69%	-4.94%
Pre Tax Income Margin	15.05%	8.65%	38.34%	-20.49%	-10.31%	-24.34%	-11.01%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	10.01	6.12	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-0.18	-1.32	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	5.73	6.12	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-4.46	-1.32	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.50%

No quarterly metrics and ratios for Evotec are available.

Financials Breakdown Chart

Frequently Asked Questions About Evotec's Financials

When does Evotec's financial year end?

According to the most recent income statement we have on file, Evotec's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Evotec's net income changed over the last 6 years?

Evotec's net income appears to be on an upward trend, with a most recent value of -$121.49 million in 2025, falling from $41.87 million in 2019. The previous period was -$202.96 million in 2024.

What is Evotec's operating income?

Evotec's total operating income in 2025 was -$65.23 million, based on the following breakdown:

Total Gross Profit: $134.05 million
Total Operating Expenses: $199.28 million

How has Evotec's revenue changed over the last 6 years?

Over the last 6 years, Evotec's total revenue changed from $501.02 million in 2019 to $925.23 million in 2025, a change of 84.7%.

How much debt does Evotec have?

Evotec's total liabilities were at $526.12 million at the end of 2025, a 1.0% decrease from 2024, and a 41.3% decrease since 2020.

How much cash does Evotec have?

In the past 5 years, Evotec's cash and equivalents has ranged from $317.14 million in 2024 to $791.50 million in 2021, and is currently $491.17 million as of their latest financial filing in 2025.

How has Evotec's book value per share changed over the last 6 years?

Over the last 6 years, Evotec's book value per share changed from 0.00 in 2019 to 5.38 in 2025, a change of 537.9%.

Related Companies

Financial statements for OTCMKTS:EVTCY last updated on 4/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evotec (EVTCY) Financials

Financials Breakdown Chart

Frequently Asked Questions About Evotec's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evotec (EVTCY) Financials

Annual Income Statements for Evotec

Quarterly Income Statements for Evotec

Annual Cash Flow Statements for Evotec

Quarterly Cash Flow Statements for Evotec

Annual Balance Sheets for Evotec

Quarterly Balance Sheets for Evotec

Annual Metrics And Ratios for Evotec

Quarterly Metrics And Ratios for Evotec

Financials Breakdown Chart

Frequently Asked Questions About Evotec's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools